Objective To evaluate the impact of non-blinded outcome assessment on estimated
treatment effects in randomised clinical trials with binary outcomes. Design Systematic …

Cytomegalovirus (CMV) infection of the CNS occurs most commonly in patients with severe
immunosuppression such as those with advanced HIV infection (ie AIDS) or those who have …

Valganciclovir (Valcyte®, Roche), a prodrug of the deoxyguanosine analog ganciclovir
(Cytovene®, Roche), is indicated for induction and maintenance treatment of …

Objective: Unusual clinical course Background: Cytomegalovirus (CMV) infection has been
well described as an opportunistic infection of patients with human immunodeficiency virus …

The incidence of cytomegalovirus (CMV) retinitis appears to be declining with improved
treatment protocols for HIV and prophylaxis protocols for other high risk patients. Despite …

Cytomegalovirus (CMV) retinitis is a sight-threatening illness that results from the
reactivation of CMV in the retina of patients with end-stage AIDS. Valganciclovir, a prodrug …

Objective: Funduscopy was compared with retinal photographs in the documentation of
progression of cytomegalovirus (CMV) retinitis. Setting: Clinical centres provided oral …

Immunoglobulin A (IgA) is the most abundant immunoglobulin present in mucosal secretions
as secretory IgA (sIgA). Furthermore, although not as prominent, IgA is present in the …

With the introduction of HAART in the 1990s, there has been a fall in the incidence of CMV-R
in the United States, and there is also a reducing proportion of Caucasian homosexual …

Objectives. The objectives of these studies were to investigate the epidemiology of selected
measures of CMV retinitis in patients with AIDS and to evaluate these measures as …